Skip to main content
Premium Trial:

Request an Annual Quote

JGI to Grant $1.2M to Genomic Technology Projects

NEW YORK (GenomeWeb) – The US Department of Energy's Joint Genome Institute plans to grant $1.2 million to fund up to four projects for up to two years each under its Emerging Technological Opportunities Program.

The University of California, Lawrence Berkeley National Laboratory is seeking letters of intent for the JGI's ETOP through Aug. 30. Finalists will be notified by Sept. 20 and asked to submit a full proposal due Oct. 20, with a target start date of Jan. 1, 2016.

The JGI expects to support projects that involve methods for targeted sequencing of uncultivated microbes; technologies to access single plant cells from various complex tissues for RNA-seq and other genomic assays; and  computational approaches to resolve genomes from metagenomes.

It also said that projects eligible for funding include reference-independent comparative metagenomics; scalable data storage solutions that support metagenomic, microbial, fungal, and plant genomic portals;, and the development of software for the Intel XeonPhi architecture that can run JGI's algorithms and can run efficiently on the National Energy Research Scientific Computing Center's supercomputer.

At the end of the funding period, the projects will be evaluated for longer-term future funding.

The JGI last funded projects under ETOP in 2013. The projects involved single-cell metagenomics; gene synthesis technology; cell sorting, mapping and assembly methods; methods for genome assembly from metagenomic samples; and techniques for fungal culturing.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.